Associate/Sr. Associate, Asset Acquisition

GondolaBio Service Co • Palo Alto, CA

11d

About The Position

GondolaBio’s Asset Acquisition team is seeking an Associate/Sr. Associate to help define new programs at the intersection of science and business. The team finds and evaluates therapeutic ideas, emphasizing the scientific rationale behind therapeutic strategies, and determines which programs GondolaBio will pursue. It works closely with the Investment Committee, composed of experienced drug developers and academic scientists. This role will help shape the company’s culture and business development and serve as a face of the organization.

The successful candidate will identify and assess promising programs for genetically driven diseases, build scientific and business cases for potential investments, and collaborate with internal and external experts. The role requires patient-focused judgment, scientific curiosity, independence, comfort with ambiguity, and the ability to execute quickly in a fast-paced environment.

Requirements

• Patient-driven, with a commitment to the impact of the work on patients.
• Advanced technical degree (PhD, MD, or MD+PhD) in life sciences and/or medicine from a top-tier academic institution.
• Previous experience in at least one of the following: 1–4 years of postdoctoral or residency training; management consulting or venture capital experience at a top-tier firm with significant diligence experience; or a business development role at a biotech or life science startup.
• Strong aptitude for science and detailed scientific curiosity.
• Demonstrated scientific achievement, such as lead-author preprints or publications, grants, patents, scholarships, or awards.
• Ability to thrive in an intense environment.
• Comfort with significant ambiguity and unpredictable drug development processes.
• Ability to work independently, identify problems, locate resources, and find data-driven solutions.
• Strong sense of urgency and ability to optimize for speed.

Responsibilities

• Identify promising preclinical or early clinical-stage programs for genetically driven diseases through literature review, engagement with academic and industry experts, and internal development efforts.
• Evaluate all aspects of potential therapeutic programs, from genetic rationale and preclinical evidence to development plans and clinical trial design.
• Build scientific and business cases for potential investments that target the genetic source of a disease.
• Interface with leading academics, patient advocacy groups, biotechs, and entrepreneurs.
• Lead internal discussions with management and the Investment Committee.
• Establish a focused investment strategy and identify new investment opportunities.
• Coordinate with internal clinical, commercial, and disease subject-matter experts to assess projects in depth.

Benefits

• Patient Days with opportunities to hear directly from people living with the conditions the company seeks to address.
• Learning and development resources.
• Market-competitive compensation and benefits package, including base pay, performance bonus, equity, and health, welfare, and retirement programs.
• Flexible PTO.
• Potential for rapid career advancement for strong performers.
• Potential to work on multiple BridgeBio Pharma programs across therapeutic areas.
• Partnerships with leading institutions.

What This Job Offers

• Job Type: Full-time
• Career Level: Entry Level
• Education Level: Ph.D. or professional degree